Tags

Type your tag names separated by a space and hit enter

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China.
Hum Vaccin Immunother. 2022 Nov 30; 18(6):2099210.HV

Abstract

This study was conducted to ascertain whether people in China would be willing to pay for an inactivated COVID-19 vaccine booster dose. An online survey estimating participants' willingness to pay (WTP) for a booster dose of COVID-19 vaccine was conducted in Taizhou, China. The participants received ane-mail or e-poster on WeChat. A total of 1576 subjects participated the survey. A total of 66.4% (1046/1576) of the respondents were willing to pay for a booster dose of COVID-19 vaccine for themselves. Using binary logistic regression analysis, the following factors were significantly related to a WTP for a booster dose of COVID-19 vaccine: 1) confidence in the safety of the COVID-19 vaccines (high vs. low, OR: 4.30, 95%CI: 1.61-11.43), 2) confidence in the preventive effectiveness of the COVID-19 vaccines against SARS-CoV-2 virus (moderate vs. little, OR: 1.76, 95%CI: 1.30-2.38; great vs. little, OR: 2.244, 95%CI: 1.62-3.12), and 3) COVID-19 vaccine hesitancy (unhesitant vs. very unhesitant, OR: 0.67, 95%CI: 0.45-1.02; hesitant vs. very unhesitant, OR: 0.29, 95%CI: 0.19-0.44; very hesitant vs. very unhesitant, OR: 0.09, 95%CI: 0.03-0.27). This study revealed that a moderate proportion of participants responded that they would be willing to pay for a booster dose of COVID-19 vaccine. These findings suggest the importance of a detailed assessment and a health education plan that better understands the population's risk perception as well as the potential health risks in China.

Links

PMC Free PDF

Authors+Show Affiliations

Tung TH
Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.
Lin XQ
Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.
Chen Y
Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.
Zhang MX
Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.
Zhu JS
Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

MeSH

HumansCOVID-19 VaccinesSARS-CoV-2COVID-19ChinaVaccination

Pub Type(s)

Journal Article

Language

eng

PubMed ID

35880816

Citation

Tung, Tao-Hsin, et al. "Willingness-to-pay for a Booster Dose of Inactivated SARS-CoV-2 Vaccine in Taizhou, China." Human Vaccines & Immunotherapeutics, vol. 18, no. 6, 2022, p. 2099210.
Tung TH, Lin XQ, Chen Y, et al. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. Hum Vaccin Immunother. 2022;18(6):2099210.
Tung, T. H., Lin, X. Q., Chen, Y., Zhang, M. X., & Zhu, J. S. (2022). Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. Human Vaccines & Immunotherapeutics, 18(6), 2099210. https://doi.org/10.1080/21645515.2022.2099210
Tung TH, et al. Willingness-to-pay for a Booster Dose of Inactivated SARS-CoV-2 Vaccine in Taizhou, China. Hum Vaccin Immunother. 2022 Nov 30;18(6):2099210. PubMed PMID: 35880816.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. AU - Tung,Tao-Hsin, AU - Lin,Xiao-Qing, AU - Chen,Yan, AU - Zhang,Mei-Xian, AU - Zhu,Jian-Sheng, Y1 - 2022/07/26/ PY - 2022/7/27/pubmed PY - 2022/12/15/medline PY - 2022/7/26/entrez KW - COVID-19 KW - China KW - booster dose KW - willingness-to-pay SP - 2099210 EP - 2099210 JF - Human vaccines & immunotherapeutics JO - Hum Vaccin Immunother VL - 18 IS - 6 N2 - This study was conducted to ascertain whether people in China would be willing to pay for an inactivated COVID-19 vaccine booster dose. An online survey estimating participants' willingness to pay (WTP) for a booster dose of COVID-19 vaccine was conducted in Taizhou, China. The participants received ane-mail or e-poster on WeChat. A total of 1576 subjects participated the survey. A total of 66.4% (1046/1576) of the respondents were willing to pay for a booster dose of COVID-19 vaccine for themselves. Using binary logistic regression analysis, the following factors were significantly related to a WTP for a booster dose of COVID-19 vaccine: 1) confidence in the safety of the COVID-19 vaccines (high vs. low, OR: 4.30, 95%CI: 1.61-11.43), 2) confidence in the preventive effectiveness of the COVID-19 vaccines against SARS-CoV-2 virus (moderate vs. little, OR: 1.76, 95%CI: 1.30-2.38; great vs. little, OR: 2.244, 95%CI: 1.62-3.12), and 3) COVID-19 vaccine hesitancy (unhesitant vs. very unhesitant, OR: 0.67, 95%CI: 0.45-1.02; hesitant vs. very unhesitant, OR: 0.29, 95%CI: 0.19-0.44; very hesitant vs. very unhesitant, OR: 0.09, 95%CI: 0.03-0.27). This study revealed that a moderate proportion of participants responded that they would be willing to pay for a booster dose of COVID-19 vaccine. These findings suggest the importance of a detailed assessment and a health education plan that better understands the population's risk perception as well as the potential health risks in China. SN - 2164-554X UR - https://www.unboundmedicine.com/medline/citation/35880816/Willingness_to_pay_for_a_booster_dose_of_inactivated_SARS_CoV_2_vaccine_in_Taizhou_China_ DB - PRIME DP - Unbound Medicine ER -